PubMed:32846167 / 823-945
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T9 | 80-82 | Body_part | denotes | HS | http://purl.org/sig/ont/fma/fma63023 |
T10 | 86-90 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 86-90 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T15 | 91-101 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T16 | 106-121 | Disease | denotes | Type 2 diabetes | http://purl.obolibrary.org/obo/MONDO_0005148 |
T17 | 113-121 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 86-90 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T5 | 86-90 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T17 | 80-82 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056|http://purl.obolibrary.org/obo/CHEBI_28815 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T6 | 106-121 | Phenotype | denotes | Type 2 diabetes | http://purl.obolibrary.org/obo/HP_0005978 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 65-76 | http://purl.obolibrary.org/obo/GO_0009056 | denotes | degradation |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 0-122 | Sentence | denotes | Several studies have also shown the importance of countering the degradation of HS in lung infections and Type 2 diabetes. |
T5 | 0-122 | Sentence | denotes | Several studies have also shown the importance of countering the degradation of HS in lung infections and Type 2 diabetes. |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 0-122 | Sentence | denotes | Several studies have also shown the importance of countering the degradation of HS in lung infections and Type 2 diabetes. |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T3 | 80-82 | GlycoEpitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
73 | 86-101 | Disease | denotes | lung infections | MESH:D012141 |
74 | 106-121 | Disease | denotes | Type 2 diabetes | MESH:D003924 |